IL10 and COVID-19: The measurement of IL-10 and IL-12 (p70) levels on admission may be useful for the identification of hypertensive patients at greater risk of COVID-19 progression, particularly in the presence of classical clinical comorbidities (obesity, diabetes, and extensive lung involvement).